`
 
Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 
11th US-India BioPharma & Healthcare Summit, Thursday, May 18, 2017


Some of the Speakers and Participants


Dr. Andrew Plump
CMO, CSO & Board Member
Takeda Pharmaceuticals

Dr. James Bradner
President
Novartis Institutes for BioMedical Research

Dr. Richard Moscicki
Deputy Center Director- CDER
U.S. Food & Drug Administration

Dr. William Hait
Global Head of R&D
Janssen Pharmaceutical- J&J

Dr. G N Singh*
Drug Controller General of India
CDSO
Ministry of Health and Family Welfare

Dr. Martin Mackay
EVP, Global Head of R&D
Alexion Pharmaceuticals

Hari S Bhartia
Co-Chairman
Jubilant Life Sciences

Sanat Chattopadhyay
President- Merck Manufacturing Division
Merck & Co.

Christopher Viehbacher
Managing Partner
Gurnet Point Capital

Dr. Elias Zerhouni*
President - Global R&D
Sanofi

Dr. Stephen Caddick
Director of Innovation
Wellcome Trust

Dr. William W. Chin
EVP & Chief Medical Officer
PhRMA

Dr. David Nicholson
Chief R&D Officer
Allergan

Dr. Christopher Austin
Director- NCATS
National Institutes of Health

Dr. Gagandeep Kang
Executive Director
THISTI

Michael Nally
President
Merck Vaccines

Dr. Alfred Sandrock
Executive Vice President & CMO
Biogen

Dr. David Meeker
Executive Vice President
Sanofi Genzyme

Dr. Johan Van Hoof
TA Head- Infectious Diseases & Vaccines
Janssen Pharmaceutical -J&J

Dr. Jeffrey Engelman
Global Head of Oncology Research
Novartis Institutes for BioMedical Research

Dr. Michael Rosenblatt
Chief Medical Officer
Flagship Pioneering

Dr. Wim Parys
Head of R&D- Global Public Health
Janssen Pharmaceutical -J&J

Dr. Mark Feinberg
President and CEO
International AIDS Vaccine Initiative

Dr. Steve Uden
Head of Research
Alexion Pharmaceuticals

Dr. Edward Benz
President & CEO Emeritus
Dana-Farber Cancer Institute

K.V. Subramaniam
President
Reliance Life Sciences

Dr. Rakesh Jain
Prof. of Tumor Biology
MGH/Harvard Medical School

Dr. Petra Kaufmann
Director- Office of Rare Diseases Research
National Institutes of Health

Dr. Robert Urban
Global Head
Johnson & Johnson Innovation

Dr. Jim Burns
President and CEO
Casebia Therapeutics

Dr. Sridaran Natesan
Vice President- Strategic Initiatives
Sanofi

Dr. Kurt Stoeckli
President & CSO
Glenmark Pharmaceuticals

Dr. Amrit Ray
Chief Medical Officer
Janssen Pharmaceutical

Dr. Vijay Kuchroo
Director
Evergrande Center
Brigham & Women's Hospital/HMS

Manni Kantipudi
Chief Executive Officer
GVK Biosciences

Dr. Tsutomu Une
Senior Corporate Advisor
GCA Corporation

Dr. Sanjeev Sinha
Professor of Medicine
All India Institute of Medical Sciences

Philippe Lopes-Fernandes
Senior Vice-President
EMD Serono

Ravdeep Anand
President
Dystrophy Annihilation Research Trust

Dr. Niranjan Sardesai
Chief Operating Officer
Inovio

Paul Sekhri
President & CEO
Lycera

Dr. Ole Isacson
Professor of Neurology
Harvard Medical School

Dr. Timothy Clackson
President of R&D and CSO
Ariad

Dr. Giuseppe Ciaramella
Chief Scientific Officer
Valera

Jason Rhodes
Partner
Atlas Venture
Pharmasia News   Biospectrum India Online
© 2007 - USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us